Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
Behavioral Sciences (Basel, Switzerland)
|
May 27, 2026
Personalized Music Listening and Autobiographical Narration in Nursing Home Residents: Linguistic and Qualitative Findings from a Pilot Study
Chiara Rossi, Fabio Frisone, Francesca De Salve, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 15, 2007
The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration
Daniela Belloni, Silvia Scabini, Chiara Foglieni, et al.
Cancer Research
|
February 24, 2019
Spatiotemporal Regulation of Tumor Angiogenesis by Circulating Chromogranin A Cleavage and Neuropilin-1 Engagement
Alice Dallatomasina, Anna Maria Gasparri, Barbara Colombo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 12, 2019
Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity
Carmine Rocca, Francesco Scavello, Barbara Colombo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
September 29, 2012
Increased low-grade inflammation is associated with lack of functional response to carvedilol in patients with systolic heart failure
Gabriele Fragasso, Roberto Spoladore, Francesco Maranta, et al.
Healthcare (Basel, Switzerland)
|
August 26, 2022
Aging and Psychological Well-Being: The Possible Role of Inhibition Skills
Giulia Fusi, Massimiliano Palmiero, Sara Lavolpe, et al.
Oncoimmunology
|
September 14, 2016
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease
Elisabetta Ferrero, Angelo Corti, Julien Haroche, et al.
Plos One
|
May 4, 2018
Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms
Andrea Corsello, Luigi Di Filippo, Sara Massironi, et al.
Plos One
|
April 25, 2022
Chromogranin A plasma levels predict mortality in COVID-19
Rebecca De Lorenzo, Clara Sciorati, Giuseppe A Ramirez, et al.
Oncotarget
|
May 21, 2016
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models
Mimma Bianco, Anna Gasparri, Luca Generoso, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
Behavioral Sciences (Basel, Switzerland)
|
May 27, 2026
Personalized Music Listening and Autobiographical Narration in Nursing Home Residents: Linguistic and Qualitative Findings from a Pilot Study
Chiara Rossi, Fabio Frisone, Francesca De Salve, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 15, 2007
The vasostatin-I fragment of chromogranin A inhibits VEGF-induced endothelial cell proliferation and migration
Daniela Belloni, Silvia Scabini, Chiara Foglieni, et al.
Cancer Research
|
February 24, 2019
Spatiotemporal Regulation of Tumor Angiogenesis by Circulating Chromogranin A Cleavage and Neuropilin-1 Engagement
Alice Dallatomasina, Anna Maria Gasparri, Barbara Colombo, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
April 12, 2019
Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity
Carmine Rocca, Francesco Scavello, Barbara Colombo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)
|
September 29, 2012
Increased low-grade inflammation is associated with lack of functional response to carvedilol in patients with systolic heart failure
Gabriele Fragasso, Roberto Spoladore, Francesco Maranta, et al.
Healthcare (Basel, Switzerland)
|
August 26, 2022
Aging and Psychological Well-Being: The Possible Role of Inhibition Skills
Giulia Fusi, Massimiliano Palmiero, Sara Lavolpe, et al.
Oncoimmunology
|
September 14, 2016
Plasma Chromogranin A as a marker of cardiovascular involvement in Erdheim-Chester disease
Elisabetta Ferrero, Angelo Corti, Julien Haroche, et al.
Plos One
|
May 4, 2018
Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms
Andrea Corsello, Luigi Di Filippo, Sara Massironi, et al.
Plos One
|
April 25, 2022
Chromogranin A plasma levels predict mortality in COVID-19
Rebecca De Lorenzo, Clara Sciorati, Giuseppe A Ramirez, et al.
Oncotarget
|
May 21, 2016
Inhibition of chronic lymphocytic leukemia progression by full-length chromogranin A and its N-terminal fragment in mouse models
Mimma Bianco, Anna Gasparri, Luca Generoso, et al.
Page
of 7